Cipla said on Wednesday that Yusuf Khwaja Hamied (77), the company’s CMD, would retire as MD on March 31, after serving for 52 years. Hamied, however, will continue to be the chairman in a non-executive role, effective April 1. “Nothing has changed. We have a strong management team in place, with a professional CEO and three family members in the business,” Hamied told FE. “I will not be involved on a day-to-day basis, but will be more like a godfather.” MK Hamied, younger brother to YK Hamied, is joint MD of Cipla. In 2010, Kamil Hamied, son of MK Hamied was inducted as a member of the Cipla management team. Samina Vaziralli, MK Hamied’s daughter, has also joined the company. YK Hamied, a staunch campaigner of process patents, had caught international attention when, in 2001, Cipla said it would make its triple cocktail of antiretroviral drugs available in developing countries for $350 per patient per year.
Mukund Govind Rajan in new role at Tatas
In the first major executive changes in the Tata Group after Cyrus Mistry took over as chairman in December, Tata Sons, the group holding company, named Mukund Govind Rajan as brand custodian and spokesperson for the group, with immediate effect. Rajan, who has been with the Tata Group for over 18 years, will oversee and manage all corporate communications and brand-related activities for the group in India and overseas. He will also serve as the chief ethics officer of the group
Be the first to comment.